Literature DB >> 22425169

Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol.

Brian H Shirts1, Michael T Howard, Sandra J Hasstedt, M Nazeem Nanjee, Stacey Knight, John F Carlquist, Jeffrey L Anderson, Paul N Hopkins, Steven C Hunt.   

Abstract

OBJECTIVES: Vitamin D and serum lipid levels are risk factors for cardiovascular disease. We sought to determine if vitamin D (25OHD) interacts at established lipid loci potentially explaining additional variance in lipids.
METHODS: 1060 individuals from Utah families were used to screen 14 loci for SNPs potentially interacting with dietary 25OHD on lipid levels. Identified putative interactions were evaluated for (1) greater effect size in subsamples with winter measures, (2) replication in an independent sample, and (3) lack of gene-environment interaction for other correlated dietary factors. Maximum likelihood models were used to evaluate interactions. The replicate sample consisted of 2890 individuals from the Family Heart Study. Putative 25OHD receptor binding site modifying SNPs were identified and allele-specific, 25OHD-dependent APOA5 promoter activity examined using luciferase expression assays. An additional sample with serum 25OHD measures was analyzed.
RESULTS: An rs3135506-25OHD interaction influencing HDL-C was identified. The rs3135506 minor allele was more strongly associated with low HDL-C in individuals with low winter dietary 25OHD in initial and replicate samples (p=0.0003 Utah, p=0.002 Family Heart); correlated dietary factors did not explain the interaction. SNP rs10750097 was identified as a putative causative polymorphism, was associated with 25OHD-dependent changes in APOA5 promoter activity in HEP3B and HEK293 cells (p<0.01), and showed similar interactions to rs3135506 in family cohorts. Linear interactions were not significant in samples with serum 25OHD measures; however, genotype-specific differences were seen at deficient 25OHD levels.
CONCLUSIONS: A 25OHD receptor binding site modifying APOA5 promoter polymorphism is associated with lower HDL-C in 25OHD deficient individuals.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425169      PMCID: PMC3334480          DOI: 10.1016/j.atherosclerosis.2012.02.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  Gene-environment interaction and the mapping of complex traits: some statistical models and their implications.

Authors:  S W Guo
Journal:  Hum Hered       Date:  2000 Sep-Oct       Impact factor: 0.444

Review 2.  HDL genetics: candidate genes, genome wide scans and gene-environment interactions.

Authors:  Jose M Ordovas
Journal:  Cardiovasc Drugs Ther       Date:  2002-07       Impact factor: 3.727

3.  ConSite: web-based prediction of regulatory elements using cross-species comparison.

Authors:  Albin Sandelin; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

5.  NHLBI Family Heart Study: objectives and design.

Authors:  M Higgins; M Province; G Heiss; J Eckfeldt; R C Ellison; A R Folsom; D C Rao; J M Sprafka; R Williams
Journal:  Am J Epidemiol       Date:  1996-06-15       Impact factor: 4.897

Review 6.  Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.

Authors:  Rolf Jorde; Guri Grimnes
Journal:  Prog Lipid Res       Date:  2011-05-27       Impact factor: 16.195

7.  Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status.

Authors:  P F Jacques; S I Sulsky; J A Sadowski; J C Phillips; D Rush; W C Willett
Journal:  Am J Clin Nutr       Date:  1993-02       Impact factor: 7.045

8.  1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2.

Authors:  J Akhter; Y Lu; I Finlay; M H Pourgholami; D L Morris
Journal:  ANZ J Surg       Date:  2001-07       Impact factor: 1.872

9.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

10.  Recruitment of members of high-risk Utah pedigrees.

Authors:  R R Williams; S C Hunt
Journal:  Control Clin Trials       Date:  1987-12
View more
  7 in total

1.  Vitamin D and Major Chronic Illness.

Authors:  Sadeq A Quraishi; Carlos A Camargo
Journal:  J Restor Med       Date:  2012-09

2.  Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study.

Authors:  Kamil F Faridi; Di Zhao; Seth S Martin; Joshua R Lupton; Steven R Jones; Eliseo Guallar; Christie M Ballantyne; Pamela L Lutsey; Erin D Michos
Journal:  Nutrition       Date:  2017-02-03       Impact factor: 4.008

3.  Analysis of causal effect of APOA5 variants on premature coronary artery disease.

Authors:  Fan Wang; Isabel Z Wang; Stephen Ellis; Stephen Archacki; John Barnard; Carlos Hubbard; Eric J Topol; Qiuyun Chen; Qing K Wang
Journal:  Ann Hum Genet       Date:  2018-07-19       Impact factor: 1.670

Review 4.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

5.  Maternal vitamin D and markers of glycaemia during pregnancy in the Belfast centre of the Hyperglycaemia and Adverse Pregnancy Outcome study.

Authors:  C Casey; A McGinty; V A Holmes; A J Hill; C C Patterson; I S Young; D R McCance
Journal:  Diabet Med       Date:  2018-05-02       Impact factor: 4.359

6.  The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases.

Authors:  Ammar J Alsheikh; Sabrina Wollenhaupt; Emily A King; Jonas Reeb; Sujana Ghosh; Lindsay R Stolzenburg; Saleh Tamim; Jozef Lazar; J Wade Davis; Howard J Jacob
Journal:  BMC Med Genomics       Date:  2022-04-01       Impact factor: 3.063

7.  Polymorphisms of the 11q23.3 Locus Affect the Risk and Mortality of Coronary Artery Disease.

Authors:  Tomasz Iwanicki; Joanna Iwanicka; Anna Balcerzyk-Matić; Tomasz Nowak; Katarzyna Mizia-Stec; Paweł Bańka; Artur Filipecki; Jolanta Krauze; Alicja Jarosz; Sylwia Górczyńska-Kosiorz; Anna Ochalska-Tyka; Iwona Żak; Paweł Niemiec
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.